Boothwyn Pharmacy LLC 2025-09-10 Health serious FDA
Health · FDA · Recall #FDA-D-0608-2025
Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy Recall
Issued September 10, 2025 · Boothwyn Pharmacy LLC
In September 2025, Boothwyn Pharmacy LLC recalled the Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Subpotent Drug
What you should do
- 1 Stop using Semaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn Pharmacy right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Boothwyn Pharmacy LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Boothwyn Pharmacy LLC
- Category
- Health
- Recall date
- September 10, 2025
- Units affected
- Not reported
- Sold at
- U.S. Nationwide
- Recall number
- FDA-D-0608-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Boothwyn Pharmacy LLC has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.